Hicks Derek

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
3
Insider Sells Sum
$260,835.30

Insider Activity of Hicks Derek

According to the SEC Form 4 filings, Hicks Derek, being in a position of

  1. EVP, Chief Business Officer at Intellia Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 6502 shares for $79,194,
    over all time since 2023-01-04, has bought 0 shares, and sold 12191 share for $260,835.

The largest sale of all time was on 2024-01-03 and amounted to 3877 shares of Intellia Therapeutics, Inc. for $114,216.

Biography of Hicks Derek

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$79,1941100

Comparison of Insiders on Amount of Buys and Sells

2025-01-03SaleIntellia Therapeutics, Inc.
NTLA
EVP, Chief Business Officer
6,502
0.0064%
$12.18$79,194-16.82%
2024-01-03SaleIntellia Therapeutics, Inc.
NTLA
EVP, Chief Business Officer
3,877
0.0043%
$29.46$114,216-22.09%
2023-01-04SaleIntellia Therapeutics, Inc.
NTLA
EVP, Chief Business Officer
1,812
0.002%
$37.21$67,425-3.42%
Total: 3
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.